14 vs 24 Weeks HCV Treatment to Genotype 2/3 Patients With Rapid Virological Response

NCT00308048 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

435

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis C Virus Infection

Interventions

DRUG: Pegylated Interferon alfa 2b and ribavirin

Sponsor

Ullevaal University Hospital

Collaborators

[object Object]